Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05560763 · ClinicalTrials.gov registry record · NA
FlowTriever2 Pulmonary Embolectomy Clinical Study
A NA study, sponsored by Inari Medical.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05560763 is a NA study that has completed, run by Inari Medical. The registered enrollment target is 50 participants.
The verdict
NCT05560763, a NA study, has completed, sponsored by Inari Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The FLARE-FT2 confirmatory study is a prospective, single-arm, multicenter study of the FlowTriever2 Catheter for mechanical thrombectomy of pulmonary embolism (PE).
Interventions
- DEVICE FlowTriever2 Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2024-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05560763
The ClinicalTrials.gov registry entry for NCT05560763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FlowTriever2 Catheter is the first listed.
NCT05560763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05560763 about?
NCT05560763 is a clinical study titled "FlowTriever2 Pulmonary Embolectomy Clinical Study". The FLARE-FT2 confirmatory study is a prospective, single-arm, multicenter study of the FlowTriever2 Catheter for mechanical thrombectomy of pulmonary embolism (PE).
What is the current status of trial NCT05560763?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-02-14. Estimated completion is 2024-09-09.
What interventions are being tested in trial NCT05560763?
The interventions under investigation include: FlowTriever2 Catheter (DEVICE).
Who is sponsoring clinical trial NCT05560763?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.